| Gender |
No. |
% |
| Female |
17 |
44.4 |
| Male |
22 |
55.6 |
| Age |
31 (7-64) |
|
| Age at transplantation Lymphoms |
34 (18-65) |
|
| Non Hodgkin Lymphoma |
| Anaplastic T cell |
5 |
12.8 |
| Cytotoxic T cell |
5 |
12.8 |
| Mantle cell |
4 |
10.3 |
| DLBC |
3 |
7.7 |
| Centrofacial T cell |
3 |
7.7 |
| Angioimmunoblastic T |
3 |
7.7 |
| NOS T cell |
1 |
2.6 |
| Hodgkin Lymphoma |
|
| Nodular Sclerosis |
6 |
15.4 |
| Mixed Cellularity |
6 |
15.4 |
| Lymphocyte depleted |
1 |
2.6 |
| NOS LH |
2 |
5.1 |
| Stage at Transplantation |
| 1 CR |
10 |
25.6 |
| 2 CR |
15 |
38.4 |
| 3 CR |
2 |
5.2 |
| Relapse |
4 |
10.2 |
| 1 PR |
2 |
5.1 |
| 2 PR |
5 |
12.8 |
| 3 PR |
1 |
2.7 |
| Neutrophil graft |
11 (9-22) |
|
| Platelet graft |
10 (0-29) |
|
|